Infectious bronchitis virus inhibits activation of the TLR7 pathway, but not the TLR3 pathway

12Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Various strains of infectious bronchitis virus (IBV) cause different forms of infectious bronchitis with different clinical signs. Here, primary chicken embryo kidney (CEK) cells and specific-pathogen-free (SPF) chickens were infected with three pathogenic IBV strains, and it was observed that the TLR7-MYD88 pathway was inhibited but the TLR3-TIRF pathway was activated. After treatment with poly(I:C)-LMW, poly (I:C)-LMW/LyoVec, and Imiquimod, the replication of IBV was significantly suppressed after 24 h. However, treatment with TLR3 pathway inhibitors such as Pepinh-TRIF, celastrol, chloroquine, and BX795 resulted in increased replication of IBV after 36 h. These results also showed that chloroquine and celastrol were most effective inhibitors of the antiviral response at 48 hpi.

Cite

CITATION STYLE

APA

Zhu, J., Xu, S., Li, X., Wang, J., Jiang, Y., Hu, W., & Ruan, W. (2020). Infectious bronchitis virus inhibits activation of the TLR7 pathway, but not the TLR3 pathway. Archives of Virology, 165(9), 2037–2043. https://doi.org/10.1007/s00705-020-04690-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free